Follow
Matthew Silvestrini
Matthew Silvestrini
Sr. Clinical Research Scientist, Verily Life Sciences
Verified email at ucdavis.edu
Title
Cited by
Cited by
Year
Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols
MT Silvestrini, ES Ingham, LM Mahakian, A Kheirolomoom, Y Liu, BZ Fite, ...
JCI insight 2 (6), 2017
1002017
Branched ocular implant
M Silvestrini, TA Silvestrini
US Patent App. 12/852,407, 2011
892011
CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols
JW Seo, R Tavaré, LM Mahakian, MT Silvestrini, S Tam, ES Ingham, ...
Clinical Cancer Research 24 (20), 4976-4987, 2018
842018
Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation
M Chavez, MT Silvestrini, ES Ingham, BZ Fite, LM Mahakian, SM Tam, ...
Theranostics 8 (13), 3611, 2018
632018
Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies
MB Potts, MT Silvestrini, DA Lim
Surgical neurology international 4 (Suppl 1), S22, 2013
612013
Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer
BZ Fite, J Wang, AJ Kare, A Ilovitsh, M Chavez, T Ilovitsh, N Zhang, ...
Scientific reports 11 (1), 927, 2021
532021
Toward personalized peptide-based cancer nanovaccines: a facile and versatile synthetic approach
H Kakwere, ES Ingham, R Allen, LM Mahakian, SM Tam, H Zhang, ...
Bioconjugate chemistry 28 (11), 2756-2771, 2017
382017
Nanoengineered surfaces enhance drug loading and adhesion
KE Fischer, A Jayagopal, G Nagaraj, RH Daniels, EM Li, MT Silvestrini, ...
Nano letters 11 (3), 1076-1081, 2011
342011
Combining activatable nanodelivery with immunotherapy in a murine breast cancer model
A Kheirolomoom, MT Silvestrini, ES Ingham, LM Mahakian, SM Tam, ...
Journal of controlled release 303, 42-54, 2019
332019
CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery
A Kheirolomoom, ES Ingham, LM Mahakian, SM Tam, MT Silvestrini, ...
Journal of Controlled Release 220, 253-264, 2015
312015
Radially branched deployment for more efficient cell transplantation at the scale of the human brain
MT Silvestrini, D Yin, VG Coppes, P Mann, AJ Martin, PS Larson, PA Starr, ...
Stereotactic and functional neurosurgery 91 (2), 92-103, 2013
262013
Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment
MT Silvestrini, D Yin, AJ Martin, VG Coppes, P Mann, PS Larson, PA Starr, ...
Molecular Therapy 23 (1), 119-129, 2015
222015
Postablation immune microenvironment: synergy between interventional oncology and immuno-oncology
DH Kim, JP Erinjeri
Seminars in Interventional Radiology 36 (04), 334-342, 2019
192019
A syngeneic ErbB2 mammary cancer model for preclinical immunotherapy trials
Z Pénzváltó, JQ Chen, CG Tepper, RR Davis, MT Silvestrini, ...
Journal of mammary gland biology and neoplasia 24, 149-162, 2019
82019
Unimicellar hyperstars as multi-antigen cancer nanovaccines displaying clustered epitopes of immunostimulating peptides
H Kakwere, ES Ingham, R Allen, LM Mahakian, SM Tam, H Zhang, ...
Biomaterials science 6 (11), 2850-2858, 2018
82018
Microinjection catheter
DA Lim, M Silvestrini, T Desai
US Patent 10,099,034, 2018
72018
Localized nanodelivery combined with immunotherapy promotes curative anti-tumor responses in a murine breast cancer model
A Kheirolomoom, MT Silvestrini, ES Ingham, LM Mahakian, SM Tam, ...
Cancer Research 79 (13_Supplement), 3952-3952, 2019
22019
5th International Symposium on Focused Ultrasound: North Bethesda, MD, USA. 28 August-1 September 2016
M Zaaroor, A Sinai, D Goldsher, A Eran, M Nassar, I Schlesinger, J Parker, ...
Journal of Therapeutic Ultrasound 4, 1-113, 2016
22016
Abstract LB-052: activatable nanodelivery combined with CpG-ODN and anti-PD-1 achieves a complete response in directly-treated and contralateral tumors in a murine breast …
MT Silvestrini, A Kheirolomoom, ES Ingham, LM Mahakian, SM Tam, ...
Cancer Research 76 (14_Supplement), LB-052-LB-052, 2016
22016
Protocol optimization combining activatable nanodelivery with immunotherapy in a murine breast cancer model
A Kheirolomoom, M Silvestrini, L Mahakian, E Ingham, J Foiret, ...
Cancer Research 77 (13_Supplement), 4603-4603, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20